Comparative Analysis of Hospitalization Risk for Incident Heart Failure in Non-Hispanic Black vs Non-Hispanic White Individuals With Type 2 Diabetes on Empagliflozin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data
Diabetes Obes Metab 2024 Feb 15;[EPub Ahead of Print], BM Mishriky, DM Cummings, Y Fu, JR Halladay, S Jones, AD Boan, S Jones, SP Patil, JR Powell, A Adams, W IrishFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.